In patients with systolic CHF, ID is common and constitutes a strong, independent predictor of unfavourable outcome. Iron supplementation may be considered as a therapeutic approach in these patients to improve prognosis.
No takes yet. Share an insight, caveat, or question.
Jankowska et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: